CNCR vs. MEDX ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Horizon Kinetics Medical ETF (MEDX)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$13.22

Average Daily Volume

3,744

Number of Holdings *

67

* may have additional holdings in another (foreign) market
MEDX

Horizon Kinetics Medical ETF

MEDX Description The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$27.37

Average Daily Volume

1,018

Number of Holdings *

32

* may have additional holdings in another (foreign) market
Performance
Period CNCR MEDX
30 Days -13.14% -10.09%
60 Days -15.74% -12.50%
90 Days -11.75% -13.78%
12 Months 25.96% -4.11%
7 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in MEDX Overlap
ALLO F 1.18% 0.28% 0.28%
BCYC F 1.24% 1.95% 1.24%
BMY B 1.72% 6.23% 1.72%
MRK D 1.24% 3.96% 1.24%
REGN F 1.0% 3.38% 1.0%
REPL D 1.56% 0.98% 0.98%
TSVT F 1.06% 0.41% 0.41%
CNCR Overweight 60 Positions Relative to MEDX
Symbol Grade Weight
GLUE C 2.03%
EXEL B 1.9%
RVMD C 1.84%
ACLX C 1.73%
ELVN D 1.68%
XNCR B 1.66%
MRSN D 1.62%
BPMC B 1.58%
KPTI D 1.57%
GNLX F 1.56%
MGNX F 1.55%
HCM D 1.54%
SWTX C 1.47%
CRBU D 1.47%
JANX C 1.46%
ERAS C 1.46%
DAWN D 1.44%
IMCR D 1.42%
RXRX F 1.39%
SDGR C 1.39%
ARVN F 1.39%
AURA C 1.38%
LYEL F 1.35%
SNDX F 1.34%
MRUS F 1.33%
KYMR D 1.32%
RPTX F 1.32%
GERN D 1.31%
IOVA F 1.3%
RCUS F 1.29%
NRIX C 1.29%
FHTX C 1.26%
NUVB C 1.26%
BNTX C 1.25%
ZNTL F 1.25%
YMAB F 1.24%
BMEA F 1.22%
PGEN F 1.2%
CGEM F 1.2%
NUVL C 1.18%
VOR D 1.17%
GMAB F 1.17%
TYRA F 1.16%
KURA F 1.16%
ACRV F 1.15%
AUTL F 1.13%
STRO F 1.12%
LEGN D 1.1%
IDYA F 1.07%
ITOS F 0.98%
IPHA D 0.98%
SMMT D 0.97%
ACET F 0.97%
IMRX F 0.95%
IMTX F 0.93%
RLAY F 0.91%
IGMS F 0.88%
RAPT F 0.88%
FATE F 0.87%
PRLD F 0.55%
CNCR Underweight 25 Positions Relative to MEDX
Symbol Grade Weight
LLY F -15.83%
ABBV F -7.81%
AMGN F -5.96%
NVS F -5.95%
AZN F -4.86%
JNJ C -4.65%
ALNY D -4.45%
PFE F -4.04%
ALKS C -3.91%
BIIB F -3.08%
CRSP D -2.97%
IONS F -2.78%
GSK F -2.32%
BEAM D -1.51%
NTLA F -1.3%
GALT C -0.89%
HLN C -0.79%
VNDA C -0.79%
LTRN F -0.6%
EDIT F -0.53%
GEHC D -0.48%
VTRS A -0.27%
PACB F -0.13%
BLUE F -0.08%
MURA D -0.05%
Compare ETFs